activistletters
BML Capital Urges ESSA Pharma (NASDAQ: EPIX) to Pursue Liquidation or Cash Return Amid Market Challenges
Summary
On April 24, 2025, BML Capital Management, which holds 9.5% of ESSA Pharma’s outstanding shares, sent a
activistletters
Deep Track Capital (14.5%) Pushes for Board Change at Dynavax (NASDAQ: DVAX), Slams Acquisition Focus and Urges Heplisav-Centric Strategy
Summary
Deep Track Capital, holding 14.5% of Dynavax Technologies, has publicly criticized the company's strategic direction and
activistletters
Kent Lake Urges Quanterix (NASDAQ: QTRX) Shareholders to Reject Akoya Merger, Citing Value Destruction and Governance Concerns
Summary
Kent Lake Partners, a 7.7% shareholder of Quanterix, urges fellow shareholders to vote AGAINST the proposed merger with
activistletters
Askeladden Capital, Largest Shareholder of AstroNova (NASDAQ: ALOT), Calls for Board Overhaul After Years of Missed Targets and Value Destruction
Summary
Askeladden Capital, the largest shareholder of AstroNova, has nominated five board candidates, citing deep concerns over poor financial performance,
activistletters
Hartman Group Calls for Board Overhaul at Silver Star (SLVP), Citing 70% Value Erosion, Mismanagement, and Urgent Need for Liquidation
Summary
In the April 15, 2025 letter, Al Hartman urged Silver Star shareholders to vote for the replacement of the
activistletters
H Partners Launches Withhold Campaign at Harley-Davidson (NYSE: HOG), Seeks Removal of CEO Zeitz and Long-Tenured Directors Over Governance Failures and Value Destruction
Summary
H Partners, owning 9.1% of Harley-Davidson, has launched a withhold campaign targeting CEO/Chairman Jochen Zeitz, Presiding Director
activistletters
BML Capital Urges Elevation Oncology (NASDAQ: ELEV) to Liquidate and Return Cash, Opposes Reverse Merger Without Dividend
Summary
BML Capital Management, which owns 9.9% of Elevation Oncology, has urged the board to wind down operations and
activistletters
Soleus Capital Urges ESSA Pharma (EPIX) to Liquidate and Return Cash to Shareholders Amid Valuation Gap
Summary
On April 15, 2025, Soleus Capital Management, one of ESSA Pharma’s largest shareholders, sent a letter to the
activistletters
Palogic Value Pressures Open Lending (LPRO) to Pursue Strategic Alternatives, Citing Governance Concerns and Market Misvaluation
Summary
In this letter dated April 2025, Palogic Value Fund, a major shareholder of Open Lending, raised serious concerns about
activistletters
Al Hartman Slams Silver Star (SLVP) Leadership, Cites Fiduciary Breach Over Stock Grant and Gains Broad Shareholder Support for Board Ouster
Summary
In this letter, Al Hartman condemned Silver Star CEO Gerald Haddock for awarding himself 1 million shares, calling it
activistletters
Soleus Capital Urges Theratechnologies (THTX) to Engage with Future Pak’s Takeover Offer, Criticizes Management for Ignoring M&A Interest
Summary
In this letter, Soleus Capital Management urged Theratechnologies' board to seriously consider a newly announced acquisition proposal from
activistletters
AJP and Orbic Slam Sonim Technologies (SONM) Board for Rejecting Director Nominations, Allege Entrenchment and Governance Failures
Summary
In this strongly worded April 10, 2025 letter, AJP Holding Company and Orbic North America accused Sonim Technologies'
activistletters
Bulldog Investors Challenges Tejon Ranch (TRC) Over Long-Term Underperformance, Seeks Board Change to Improve Capital Allocation and Governance
Summary
In this April 7, 2025 letter, Bulldog Investors (Andrew Dakos and Phillip Goldstein) criticized Tejon Ranch Co.’s long-term
activistletters
Elliott Investment Management Pushes for Board Overhaul at Phillips 66 (PSX), Unveils 'Streamline 66' Plan to Unlock Value and End Chronic Underperformance
Summary
On April 3, 2025, Elliott Investment Management, a major shareholder in Phillips 66, urged fellow shareholders to vote the
activistletters
Askeladden Capital Seeks Board Overhaul at AstroNova (ALOT) After MTEX Acquisition Fallout and Years of Shareholder Value Destruction
Summary
In this letter, Samir Patel of Askeladden Capital Management (a 9.2% shareholder in AstroNova Inc.) criticized the company’
